(1)
Hawkes, J.; Guercio, J.; Kurup, S.; Li, X.; Lebwohl, M. Expected Spesolimab Plasma Exposure Following Intravenous and Subcutaneous Dosing in Patients With Generalized Pustular Psoriasis. J of Skin 2024, 8, s359.